Consist with the mouse [29] and human clinical data [48], here we presented that IL-21R-deficient mice exhibited reduced numbers of spleen or liver/tumor IgA+ B cells and soluble IgA during MASH-driven hepatocarcinogenesis. The gene discussed is IL21R; the disease is neoplasm.